205 related articles for article (PubMed ID: 24131485)
21. A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma.
Nakamura M; Fukumitsu N; Kamizawa S; Numajiri H; Nemoto Murofushi K; Ohnishi K; Aihara T; Ishikawa H; Okumura T; Tsuboi K; Sakurai H
J Radiat Res; 2018 Sep; 59(5):632-638. PubMed ID: 30085200
[TBL] [Abstract][Full Text] [Related]
22. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
[TBL] [Abstract][Full Text] [Related]
23. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
24. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.
Zhao JD; Liu J; Ren ZG; Gu K; Zhou ZH; Li WT; Chen Z; Xu ZY; Liu LM; Jiang GL
Radiat Oncol; 2010 Feb; 5():12. PubMed ID: 20149262
[TBL] [Abstract][Full Text] [Related]
25. A Phase 2 Study of Image-Guided Proton Therapy for Operable or Ablation-Treatable Primary Hepatocellular Carcinoma.
Iwata H; Ogino H; Hattori Y; Nakajima K; Nomura K; Hashimoto S; Hayashi K; Toshito T; Sasaki S; Mizoe JE; Shibamoto Y
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):117-126. PubMed ID: 33798564
[TBL] [Abstract][Full Text] [Related]
26. Effect of dendritic cell-based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis.
Chen C; Ma YH; Zhang YT; Zhang F; Zhou N; Wang X; Liu T; Li YM
Cytotherapy; 2018 Aug; 20(8):975-989. PubMed ID: 30072299
[TBL] [Abstract][Full Text] [Related]
27. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
Hata M; Tokuuye K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Ohara K; Matsuzaki Y; Tanaka N; Akine Y
Cancer; 2005 Aug; 104(4):794-801. PubMed ID: 15981284
[TBL] [Abstract][Full Text] [Related]
28. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
Oshiro Y; Mizumoto M; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Takizawa D; Sakurai H
Radiother Oncol; 2017 May; 123(2):240-245. PubMed ID: 28366501
[TBL] [Abstract][Full Text] [Related]
29. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
[TBL] [Abstract][Full Text] [Related]
30. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
Yoo GS; Yu JI; Park HC
World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
[TBL] [Abstract][Full Text] [Related]
31. Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma.
Lee SU; Kim TH
Clin Mol Hepatol; 2023 Oct; 29(4):958-968. PubMed ID: 37822213
[TBL] [Abstract][Full Text] [Related]
32. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
[TBL] [Abstract][Full Text] [Related]
33. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.
Takamatsu S; Yamamoto K; Maeda Y; Kawamura M; Shibata S; Sato Y; Terashima K; Shimizu Y; Tameshige Y; Sasaki M; Asahi S; Kondou T; Kobayashi S; Matsui O; Gabata T
PLoS One; 2016; 11(12):e0167155. PubMed ID: 27907063
[TBL] [Abstract][Full Text] [Related]
35. Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.
Yutani S; Shirahama T; Muroya D; Matsueda S; Yamaguchi R; Morita M; Shichijo S; Yamada A; Sasada T; Itoh K
Cancer Sci; 2017 Sep; 108(9):1732-1738. PubMed ID: 28622427
[TBL] [Abstract][Full Text] [Related]
36. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.
Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E
Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278
[TBL] [Abstract][Full Text] [Related]
37. Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival.
Sawada Y; Yoshikawa T; Nobuoka D; Shirakawa H; Kuronuma T; Motomura Y; Mizuno S; Ishii H; Nakachi K; Konishi M; Nakagohri T; Takahashi S; Gotohda N; Takayama T; Yamao K; Uesaka K; Furuse J; Kinoshita T; Nakatsura T
Clin Cancer Res; 2012 Jul; 18(13):3686-96. PubMed ID: 22577059
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
39. Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma.
Su CW; Hou MM; Huang PW; Chou YC; Huang BS; Tseng JH; Hsu CW; Chang TC; Lin SM; Lin CC
Am J Cancer Res; 2022; 12(4):1606-1620. PubMed ID: 35530291
[TBL] [Abstract][Full Text] [Related]
40. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
